Physician profile
Ryan D Carey
NPI 1790132256
$1,011.95
in general payments reported to CMS, 2019-2025
14 companies · $268 in 2025
The $268 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $39.42 · 2021: $39.55 · 2023: $231 · 2024: $315 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $813.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $253.94 | 2019-2025 | Airsupra, Breztri |
| Novo Nordisk INC | $162.91 | 2021-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $149.03 | 2023-2025 | Mounjaro, Jardiance |
| Pfizer INC. | $94.70 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.91 | 2019-2023 | Jardiance |
| Amgen INC. | $69.17 | 2024-2025 | Prolia, Evenity, Repatha |
| Exact Sciences Corporation | $40.96 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Collegium Pharmaceutical, INC. | $34.97 | 2024-2025 | Jornay Pm, Belbuca |
| Bayer Healthcare Pharmaceuticals INC. | $33.09 | 2025 | |
| Abbvie INC. | $27.19 | 2020 | |
| Glaxosmithkline, LLC. | $18.22 | 2024 | Shingrix, Arexvy |
| Philips North America LLC | $16.86 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Novartis Pharmaceuticals Corporation | $16.77 | 2024 | |
| Merck Sharp & Dohme LLC | $12.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Carey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.